PhaseBio Pharmaceuticals Inc
Filing Type: 25-NSE
Filing Date: 20221221
SEC Links
File List
Document Index
SGML Header
Raw Filing
Documents
primary_doc.xml
25-NSE
phasdelistreason.txt
EX-99.25